Figure 1.
A schematic to illustrate the effect of immunomodulatory agents in enhancing the survival of dopaminergic neurons in animal models of Parkinson’s disease by reducing microgliosis and astrogliosis (modified from Liddelow and Barres, 2017).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.